» Articles » PMID: 24131711

Characterization of the Envelope Glycoprotein of a Novel Filovirus, Lloviu Virus

Overview
Journal J Virol
Date 2013 Oct 18
PMID 24131711
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

Lloviu virus (LLOV), a novel filovirus detected in bats, is phylogenetically distinct from viruses in the genera Ebolavirus and Marburgvirus in the family Filoviridae. While filoviruses are known to cause severe hemorrhagic fever in humans and/or nonhuman primates, LLOV is biologically uncharacterized, since infectious LLOV has never been isolated. To examine the properties of LLOV, we characterized its envelope glycoprotein (GP), which likely plays a key role in viral tropism and pathogenicity. We first found that LLOV GP principally has the same primary structure as the other filovirus GPs. Similar to the other filoviruses, virus-like particles (VLPs) produced by transient expression of LLOV GP, matrix protein, and nucleoprotein in 293T cells had densely arrayed GP spikes on a filamentous particle. Mouse antiserum to LLOV VLP was barely cross-reactive to viruses of the other genera, indicating that LLOV is serologically distinct from the other known filoviruses. For functional study of LLOV GP, we utilized a vesicular stomatitis virus (VSV) pseudotype system and found that LLOV GP requires low endosomal pH and cathepsin L, and that human C-type lectins act as attachment factors for LLOV entry into cells. Interestingly, LLOV GP-pseudotyped VSV infected particular bat cell lines more efficiently than viruses bearing other filovirus GPs. These results suggest that LLOV GP mediates cellular entry in a manner similar to that of the other filoviruses while showing preferential tropism for some bat cells.

Citing Articles

Non-Ebola Filoviruses: Potential Threats to Global Health Security.

Munyeku-Bazitama Y, Edidi-Atani F, Takada A Viruses. 2024; 16(8).

PMID: 39205153 PMC: 11359311. DOI: 10.3390/v16081179.


Characterization of human tibrovirus envelope glycoproteins.

Munyeku-Bazitama Y, Saito T, Hattori T, Miyamoto H, Lombe B, Mori-Kajihara A J Virol. 2024; 98(7):e0049924.

PMID: 38953631 PMC: 11265436. DOI: 10.1128/jvi.00499-24.


Isolation and genome characterization of Lloviu virus from Italian Schreibers's bats.

Toth G, Hume A, Suder E, Zeghbib S, Abraham A, Lanszki Z Sci Rep. 2023; 13(1):11310.

PMID: 37443182 PMC: 10344946. DOI: 10.1038/s41598-023-38364-7.


The hidden diversity of ancient bornaviral sequences from X and P genes in vertebrate genomes.

Garcia B, Mukai Y, Tomonaga K, Horie M Virus Evol. 2023; 9(1):vead038.

PMID: 37360682 PMC: 10288550. DOI: 10.1093/ve/vead038.


RNA Editing as a General Trait of Ebolaviruses.

Mehedi M, Ricklefs S, Takada A, Sturdevant D, Porcella S, Marzi A J Infect Dis. 2023; 228(Suppl 7):S498-S507.

PMID: 37348869 PMC: 10651210. DOI: 10.1093/infdis/jiad228.


References
1.
Amman B, Carroll S, Reed Z, Sealy T, Balinandi S, Swanepoel R . Seasonal pulses of Marburg virus circulation in juvenile Rousettus aegyptiacus bats coincide with periods of increased risk of human infection. PLoS Pathog. 2012; 8(10):e1002877. PMC: 3464226. DOI: 10.1371/journal.ppat.1002877. View

2.
Fisher-Hoch S, McCormick J . Experimental filovirus infections. Curr Top Microbiol Immunol. 1999; 235:117-43. DOI: 10.1007/978-3-642-59949-1_8. View

3.
Dominguez-Soto A, Aragoneses-Fenoll L, Martin-Gayo E, Martinez-Prats L, Colmenares M, Naranjo-Gomez M . The DC-SIGN-related lectin LSECtin mediates antigen capture and pathogen binding by human myeloid cells. Blood. 2007; 109(12):5337-45. DOI: 10.1182/blood-2006-09-048058. View

4.
Johnson R, Bell P, Harty R . Effect of Ebola virus proteins GP, NP and VP35 on VP40 VLP morphology. Virol J. 2006; 3:31. PMC: 1502131. DOI: 10.1186/1743-422X-3-31. View

5.
Baribaud F, Pohlmann S, Leslie G, Mortari F, Doms R . Quantitative expression and virus transmission analysis of DC-SIGN on monocyte-derived dendritic cells. J Virol. 2002; 76(18):9135-42. PMC: 136426. DOI: 10.1128/jvi.76.18.9135-9142.2002. View